Evidence map›Paper›PMID 39048081›Full record

ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2024

Confirmation of large BRCA2 reversion deletions leading to reconstituted in-frame transcripts detected via circulating tumor DNA.

K A Collier, D G Stover

Abstract readLetter
In one paragraph

Article in Annals of oncology : official journal of the European Society for Medical Oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

K A CollierDivision of Medical Oncology, Ohio State University Comprehensive Cancer Center, Columbus; Pelotonia Institute for Immuno-Oncology, Ohio State University Comprehensive Cancer, Columbus.
D G StoverDivision of Medical Oncology, Ohio State University Comprehensive Cancer Center, Columbus; Pelotonia Institute for Immuno-Oncology, Ohio State University Comprehensive Cancer, Columbus; Department of Biomedical Informatics, Ohio State University, Columbus, USA. Electronic address: daniel.stover@osumc.edu.

Funding

Characterizing the immune infiltrate in muscle-invasive urothelial carcinomaK08CA277016 · NCI · OHIO STATE UNIVERSITY · PI Katharine A. Collier · 2023 to 2026
$1.1M
Training Hematology and Oncology Fellows in Clinical ResearchT32CA247815 · NCI · OHIO STATE UNIVERSITY · PI VERSCHRAEGEN, CLAIRE F., WESOLOWSKI, ROBERT · 2020 to 2024
$862k
Assay Validation of Cell-Free DNA Shallow Whole Genome Sequencing To Determine 'Tumor Fraction' in Advanced CancersUH3CA239105 · NCI · BROAD INSTITUTE, INC. · PI ADALSTEINSSON, VIKTOR, LENNON, NIALL JOHN · 2022 to 2024
$762k
Assay Validation of Cell-Free DNA Shallow Whole Genome Sequencing To Determine 'Tumor Fraction' in Advanced CancersUH2CA239105 · NCI · BROAD INSTITUTE, INC. · PI ADALSTEINSSON, VIKTOR, LENNON, NIALL JOHN · 2020 to 2021
$321k
NCI NIH HHS K08 CA277016NCI NIH HHS T32 CA247815NCI NIH HHS UH2 CA239105NCI NIH HHS UH3 CA239105
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BRCA2 ProteinCirculating Tumor DNABreast NeoplasmsFemaleHumansMiddle AgedSequence DeletionBRCA2 ProteinBRCA2 protein, humanCirculating Tumor DNA

Identifiers

PMID39048081
PMCPMC11998630

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.